Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study

NCT07746895 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

C3 Glomerulopathy (C3G)
Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)

Interventions

DRUG: Pegcetacoplan

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]